3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole

C49H83N5 — CID 155621707

IUPAC3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole
SMILESC1CCC(N2C3CCC(N4CC(C5CC(C6CCNCC6)CC(C6CCNCC6)C5)C4)CC3C3CC(N4C5CCCCC5C5CCCCC54)CCC32)CC1
InChIInChI=1S/C49H83N5/c1-2-8-39(9-3-1)53-48-16-14-40(52-31-38(32-52)37-27-35(33-18-22-50-23-19-33)26-36(28-37)34-20-24-51-25-21-34)29-44(48)45-30-41(15-17-49(45)53)54-46-12-6-4-10-42(46)43-11-5-7-13-47(43)54/h33-51H,1-32H2
InChIKeyGONZIVWGPXFJIH-UHFFFAOYSA-N
MW742.24 g/mol
LogP9.11
Rot. Bonds6

About 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole

3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole (PubChem CID 155621707) has the molecular formula C49H83N5 and a molecular weight of 742.24 g/mol. Its IUPAC name is 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole.

Molecular Properties

Compound Name3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole
PubChem CID155621707
Molecular FormulaC49H83N5
Molecular Weight742.24 g/mol
Exact Mass741.66
IUPAC Name3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole
SMILESC1CCC(N2C3CCC(N4CC(C5CC(C6CCNCC6)CC(C6CCNCC6)C5)C4)CC3C3CC(N4C5CCCCC5C5CCCCC54)CCC32)CC1
InChIInChI=1S/C49H83N5/c1-2-8-39(9-3-1)53-48-16-14-40(52-31-38(32-52)37-27-35(33-18-22-50-23-19-33)26-36(28-37)34-20-24-51-25-21-34)29-44(48)45-30-41(15-17-49(45)53)54-46-12-6-4-10-42(46)43-11-5-7-13-47(43)54/h33-51H,1-32H2
InChIKeyGONZIVWGPXFJIH-UHFFFAOYSA-N
XLogP9.11
TPSA33.78 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500742.24
LogP ≤ 59.11
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole?
The IUPAC name of 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole (CID 155621707) is 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole.
What is the SMILES notation for 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole?
The canonical SMILES for 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole is C1CCC(N2C3CCC(N4CC(C5CC(C6CCNCC6)CC(C6CCNCC6)C5)C4)CC3C3CC(N4C5CCCCC5C5CCCCC54)CCC32)CC1.
What is the InChIKey of 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole?
The InChIKey is GONZIVWGPXFJIH-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H83N5/c1-2-8-39(9-3-1)53-48-16-14-40(52-31-38(32-52)37-27-35(33-18-22-50-23-19-33)26-36(28-37)34-20-24-51-25-21-34)29-44(48)45-30-41(15-17-49(45)53)54-46-12-6-4-10-42(46)43-11-5-7-13-47(43)54/h33-51H,1-32H2.
What are the key properties of 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole?
3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole has a molecular weight of 742.24 g/mol, XLogP of 9.11, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazol-9-yl)-9-cyclohexyl-6-[3-[3,5-di(piperidin-4-yl)cyclohexyl]azetidin-1-yl]-1,2,3,4,4a,4b,5,6,7,8,8a,9a-dodecahydrocarbazole is sourced from PubChem (CID 155621707), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).